-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
A few days ago, BD announced that it would spin off its diabetes care business Diabetes Care in the first half of 2022 as a completely independent, publicly traded listed company, with the name tentatively designated "NewCo".
A few days ago, BD announced that it would spin off its diabetes care business Diabetes Care in the first half of 2022 as a completely independent, publicly traded listed company, with the name tentatively designated "NewCo".
On the same day that the news of the diabetes business spin-off was released, BD also announced its performance data for the second quarter of 2021.
Excluding one-time items, BD’s second-quarter earnings per share reached $3.